Utilization of Indocyanine Green to Aid in Identifying Sentinel Lymph Nodes in Merkel Cell Cancer
- PMID: 30463742
- DOI: 10.1016/j.jss.2018.06.070
Utilization of Indocyanine Green to Aid in Identifying Sentinel Lymph Nodes in Merkel Cell Cancer
Abstract
Background: Merkel cell carcinoma (MCC) is a relatively rare skin cancer with high rates of regional lymph node involvement and metastatic spread. National Comprehensive Cancer Network guidelines recommend sentinel lymph node biopsy (SLNB) for staging purposes. The goal of this study is to report our experience utilizing indocyanine green (ICG) fluorescence-based technology to aid in SLNB detection in MCC.
Methods: Consecutive MCC patients who underwent SLNB with radioisotope lymphoscintigraphy, with intraoperative handheld gamma probe, and ICG-based fluorescence imaging from 2012 to 2017 were prospectively studied (Cohort A). A group of historical controls that underwent SLNB for MCC with radioisotope lymphoscintigraphy and vital blue dye (VBD) (lymphazurin or methylene blue dye) was also analyzed (Cohort B).
Results: Twenty-four consecutive patients underwent SLNB with lymphoscintigraphy and ICG-based fluorescence and 11 controls underwent SLNB with lymphoscintigraphy and VBD. The localization rate by node with VBD was 63.6% and ICG-based fluorescence was 94.8%. For two patients, a positive sentinel lymph node (SLN) was detected only by ICG-based fluorescence and the nodes were not detected by gamma probe and one patient's only positive node was identified via ICG fluorescence only. VBD or gamma probe did not identify any unique positive SLNs in either cohort B or either cohort, respectively.
Conclusions: In this study, we indicate that ICG-based fluorescence is not only feasible to augment SLN identification, but it has a higher node localization rate as compared to blue dye and it was able to identify positive SLNs otherwise missed by gamma probe. This study suggests the importance of utilizing two modalities to augment SLN identification and that ICG-based fluorescence may be able to identify nodes that would have been otherwise missed by gamma probe. We will continue to follow these patients and enroll more patients in this prospective study to further determine the role that ICG-based fluorescence has in identifying sentinel lymph nodes in MCC.
Keywords: Indocyanine green; Merkel cell cancer; Sentinel node.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Indocyanine green fluorescence imaging with lymphoscintigraphy for sentinel node biopsy in head and neck melanoma.J Surg Res. 2018 Aug;228:77-83. doi: 10.1016/j.jss.2018.02.064. Epub 2018 Mar 26. J Surg Res. 2018. PMID: 29907233
-
Indocyanine Green Fluorescence Imaging with Lymphoscintigraphy for Sentinel Node Biopsy in Melanoma: Increasing the Sentinel Lymph Node-Positive Rate.Ann Surg Oncol. 2019 Oct;26(11):3550-3560. doi: 10.1245/s10434-019-07617-z. Epub 2019 Jul 16. Ann Surg Oncol. 2019. PMID: 31313036
-
Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.J Surg Oncol. 2018 Mar;117(3):336-340. doi: 10.1002/jso.24859. Epub 2017 Dec 11. J Surg Oncol. 2018. PMID: 29228459
-
The application of sentinel node radiolocalization to solid tumors of the head and neck: a 10-year experience.Laryngoscope. 2004 Jan;114(1):2-19. doi: 10.1097/00005537-200401000-00002. Laryngoscope. 2004. PMID: 14709988 Review.
-
Indocyanine Green Fluorescence Versus Blue Dye or Radioisotope Regarding Detection Rate of Sentinel Lymph Node Biopsy and Nodes Removed in Breast Cancer: A Systematic Review and Meta-Analysis.Asian Pac J Cancer Prev. 2020 May 1;21(5):1187-1195. doi: 10.31557/APJCP.2020.21.5.1187. Asian Pac J Cancer Prev. 2020. PMID: 32458621 Free PMC article.
Cited by
-
Detection of Sentinel Lymph Nodes Using Indocyanine Green After Failing Scintigraphy in Merkel Cell Carcinoma.Cureus. 2023 May 2;15(5):e38453. doi: 10.7759/cureus.38453. eCollection 2023 May. Cureus. 2023. PMID: 37273297 Free PMC article.
-
Best practices in surgical and nonsurgical management of head and neck Merkel cell carcinoma: An update.Mol Carcinog. 2023 Jan;62(1):101-112. doi: 10.1002/mc.23483. Epub 2022 Nov 11. Mol Carcinog. 2023. PMID: 36367533 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical